𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cetuximab monotherapy in advanced cervical cancer: a retrospective study with five patients

✍ Scribed by Linda Hertlein; Miriam Lenhard; Angela Kirschenhofer; Steffen Kahlert; Doris Mayr; Alexander Burges; Klaus Friese

Publisher
Springer
Year
2010
Tongue
English
Weight
148 KB
Volume
283
Category
Article
ISSN
0003-9128

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase 2 study of cetuximab in patients w
Phase 2 study of cetuximab in patients with advanced hepatocellular carcinoma
✍ Andrew X. Zhu; Keith Stuart; Lawrence S. Blaszkowsky; Alona Muzikansky; Donald P πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 131 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. Epidermal growth factor receptor (EGFR) and ligand expression is frequently seen in hepatocellular carcinoma (HCC). A phase 2 study was performed with cetuximab, a chimeric monoclonal antibody that binds specifically to EGFR, in patients with advanced HCC. ## METHODS.

Long-term results of interstitial implan
Long-term results of interstitial implant in locally advanced cervical cancer: A retrospective study of 50 cases
✍ Phuc D. Nguyen; Berchmans John; Thomas J. Carmody; Kang Huang; David Scott Mille πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 689 KB

A retrospective study was conducted to assess the impact of different clinical parameters on the survival (S), disease free survival (DFS), pelvic recurrence (LR), distant metastases (DM), and the development of major complications in 50 patients with locally advanced cervical cancer. The parameters